Vimarsana
Biggest News Aggregation in the World

Shakeel Modak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shakeel Modak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shakeel Modak Today - Breaking & Trending Today

Nivatrotamab in Patients With Relapsed/Refractory Solid Tumors - Vimarsana News

Nivatrotamab in Patients With Relapsed/Refractory Solid Tumors

Researchers are testing nivatrotamab in pediatric patients with relapsed/refractory neuroblastoma, osteosarcoma, and other GD2+ solid tumors.

Y-mAbs Announces Naxitamab Chemoimmunotherapy - Vimarsana News

Y-mAbs Announces Naxitamab Chemoimmunotherapy

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) --  Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...

CBI court acquits Chhota Rajan in 2010 double murder case due to lack of evidence - Vimarsana News

CBI court acquits Chhota Rajan in 2010 double murder case due to lack of evidence

A special CBI court has acquitted Chhota Rajan in a 2010 double murder case citing lack of evidence.

7th Rally for Rhyan game raises $52,000 for new MU Health Care Children's Hospital, pediatric cancer research - Vimarsana News

7th Rally for Rhyan game raises $52,000 for new MU Health Care Children's Hospital, pediatric cancer research

This year's Rally for Rhyan game marks the first time that the Rally for Rhyan foundation will donate to a benefactor other than pediatric cancer research, as half of the

Source: komu.com
UPDATE - Y-mAbs Announces Pipeline Update - Vimarsana News

UPDATE - Y-mAbs Announces Pipeline Update

NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...